Old drug, reworked data, new government push define company's attack on ALS

Ari Azhir set out more than 16 years ago to solve a mystery around deadly amyotrophic lateral sclerosis, the fatal muscle-wasting disease that killed baseball legend Lou Gehrig. Now Azhir, her small Los Altos, California company, Neuvivo Inc., and its academic collaborators — including those at California Pacific Medical Center and the University of California, San Francisco — may be closer to an answer. With a fresh look at data from two mid-stage clinical trials fr om years ago by a now-defunct…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news